BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30695814)

  • 1. Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease.
    Ferreira FA; Benites BD; Costa FF; Gilli S; Olalla-Saad ST
    Vox Sang; 2019 Feb; 114(2):178-181. PubMed ID: 30695814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.
    Tsiara SN; Chaidos A; Bourantas LK; Kapsali HD; Bourantas KL
    Acta Haematol; 2007; 117(3):156-61. PubMed ID: 17159338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
    de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
    J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
    Goodnough LT; Strasburg D; Riddell J; Verbrugge D; Wish J
    Clin Nephrol; 1994 May; 41(5):303-7. PubMed ID: 8050211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin or darbepoetin for patients with cancer.
    Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
    Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervals.
    Schettler V; Wieland E
    Ther Apher Dial; 2009 Feb; 13(1):80-2. PubMed ID: 19379175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of early erythropoietin use in critically ill, very-low-birthweight premature newborn infants: controlled clinical trial].
    Lima-Rogel V; Torres-Montes A; Espinosa Griesse S; Villegas Alvarez C; Hernández-Sierra F; Bissett Mandeville P; Correa González C
    Sangre (Barc); 1998 Jun; 43(3):191-5. PubMed ID: 9741224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
    Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
    Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.
    Little JA; McGowan VR; Kato GJ; Partovi KS; Feld JJ; Maric I; Martyr S; Taylor JG; Machado RF; Heller T; Castro O; Gladwin MT
    Haematologica; 2006 Aug; 91(8):1076-83. PubMed ID: 16885048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
    Durmaz O; Demirkaya M; Sevinir B
    Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential alternatives to erythrocyte transfusion in hemoglobinopathies: hydroxyurea (HU), erythropoietin (EPO), butyrate derivatives, blood substitutes].
    Bachir D; Galacteros F
    Transfus Clin Biol; 1994; 1(1):35-9. PubMed ID: 8186851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.
    Tomson CR; Edmunds ME; Chambers K; Bricknell S; Feehally J; Walls J
    Nephrol Dial Transplant; 1992; 7(8):817-21. PubMed ID: 1325614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood conservation in neurosurgery: erythropoietin and autologous donation.
    McGirr A; Pavenski K; Sharma B; Cusimano MD
    Can J Neurol Sci; 2014 Sep; 41(5):583-9. PubMed ID: 25373808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.